Zefiro Founder Announces Partial Dismissal of New York Litigation and Comments on Annual Meeting ResultsTORONTO, March 27, 2026 (GLOBE NEWSWIRE) -- Dr. Talal A. Debs, Founder of Zefiro Methane Corp. (Cboe: ZEFI) ("Zefiro" or the “Company”), is pleased to announce that his motion to dismiss of a New York civil case (the “NY Litigation”) brought by David McGrath against Dr. Debs, X Machina Capital Strategies Fund I GP LLC (“XMC”), and X Machina Capital Strategies LP (“XMST”) was granted in part. In a decision delivered March 19, 2026, a New York court dismissed multiple allegations included in the NY Litigation. Dr. Debs is confident he and XMC will prevail with respect to the remaining counts.
Zefiro Founder Updates Shareholders on British Columbia Securities Commission Ruling Ahead of Shareholder VoteRuling highlights significant governance breaches of incumbent team and XMST Group intends to enforce its rights to acquire 7.63% of the Common Shares of Zefiro
Zefiro Founder and Former Chairman Reports Initial Success in New York LitigationNY Litigation was used as a pretext for a frivolous investigation into Dr. Debs which was launched by Board at considerable expense to Shareholders
Zefiro Founder and Former Chairman Updates Shareholders on Recent Developments at the CompanyBoard has been focused on entrenchment and positive spin while delaying the opportunity for shareholders to vote on Company’s future
Zefiro Founder and Former Chairman Issues Letter to ShareholdersTORONTO, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Dr. Talal A. Debs, Founder and Director of Zefiro Methane Corp. (Cboe: ZEFI) ("Zefiro"), today issued the following letter to Zefiro shareholders:
